CSIMarket
 



Jazz Pharmaceuticals Plc  (JAZZ)
Other Ticker:  
 
 



 

What are Jazz Pharmaceuticals Plc's Business Segments?



Jazz Pharmaceuticals Plc is a global biopharmaceutical company focused on the development, manufacture, and commercialization of specialty medications to treat rare and serious medical conditions. The company has a wide array of segments, products and services that it offers to its customers worldwide. These include:

Segments:

1. Sleep and CNS Disorders: This segment focuses on developing and commercializing products to treat sleep disorders, neurological disorders, and other central nervous system conditions.

2. Hematology/Oncology: This segment focuses on developing and commercializing products to treat hematological malignancies, solid tumors, and other cancers.

3. Neuroscience: This segment develops and commercializes products to treat neurological disorders such as narcolepsy, pediatric sleep disorders, and movement disorders.

Products:

1. Xyrem (sodium oxybate) oral solution: It is an effective treatment for patients with narcolepsy with cataplexy to reduce the frequency and severity of cataplexy attacks.

2. Sunosi (solriamfetol) tablets: This product is designed to improve wakefulness in adults who experience excessive sleepiness associated with narcolepsy or obstructive sleep apnea.

3. Prialt (ziconotide) intrathecal solution: A non-opioid analgesic, this product is designed for the management of severe chronic pain, especially in patients with cancer or AIDS.

4. Defitelio (defibrotide sodium) injection: The first and only approved therapy for the treatment of severe hepatic veno-occlusive disease (VOD), a potentially fatal complication of stem cell transplants.

5. Erwinaze/Erwinase (asparaginase Erwinia chrysanthemi): This product is a component of multi-agent chemotherapeutic regimens to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma.

Services:

1. Medical Affairs: Provides information about Jazz products in the context of the healthcare landscape.

2. Regulatory Affairs: Manages regulatory approvals, including the submission of new drug applications (NDAs) for drug candidates.

3. Commercial Operations: Develops and implements commercial strategies to maximize the value of Jazzes products to patients, physicians, and other stakeholders.

4. Manufacturing: Manufactures and distributes Jazzes products for commercial use.

5. Clinical Research: Conducts clinical trials to evaluate the safety and efficacy of Jazzes products in diverse patient populations.

In conclusion, Jazz Pharmaceuticals Plc is a global biopharmaceutical company that offers a wide range of unique products and services to address the needs of patients with rare and serious medical conditions. The companyes commitment to research, development, and manufacturing of specialty medications has helped it establish a solid reputation as a leader in the medical industry.
   

Jazz Pharmaceuticals Plc Tax Rate Companies within the Major Pharmaceutical Preparations Industry


Business Segments Q4
Revenues
(in millions $)
Q4
Income
(in millions $)
(Dec 31 2023)
%
(Profit Margin)
Total 1,011.94 94.15 9.3 %

Growth rates by Segment Q4
Y/Y Revenue
%
(Dec 31 2023)
Q/Q Revenue
%
Q4
Y/Y Income
%
(Dec 31 2023)
Q/Q Income
%
Total -18.92 % 4.09 % - -35.87 %

To get more information on Jazz Pharmaceuticals Plc's Total segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com